Tail vein injection is the intravenous (IV) administration of a liquid substance into the lateral tail vein of a mouse or rat. The two lateral tail veins, located at approximately the 3 o'clock and 9 o'clock positions along the tail, are the most accessible peripheral veins in rodents and are the standard sites for IV dosing in preclinical research. Successful injection delivers the compound directly into the systemic circulation, resulting in near-immediate bioavailability.
Before injection, the tail must be warmed to dilate the lateral veins and make them visible and accessible. Common warming methods include immersion in warm water (38–40 °C) for 30–60 seconds, use of a warm lamp or heat pad, or brief restraint in a warm chamber. Over-heating must be avoided to prevent thermal injury; water temperature should not exceed 40 °C. After warming, the lateral veins are typically visible as dark lines running along the sides of the tail. The injection site should be as distal (towards the tip) as possible to allow more proximal sites to be used if the first attempt is unsuccessful.
Needle gauge is selected based on species and formulation. For mice, 27- to 30-gauge needles are standard; for rats, 25- to 27-gauge needles are appropriate. The needle is inserted bevel-up at a shallow angle (approximately 10–15°) into the lateral vein. Correct placement is indicated by lack of resistance during injection, absence of a subcutaneous bleb at the injection site, and visible clearing (blanching) of the vein lumen as the injectate displaces blood within the vessel. Formation of a subcutaneous bleb (a raised swelling under the skin), or blanching of the tail skin surrounding the injection site, indicates extravasation — the needle is not in the vein and the injection should be stopped and repositioned.
Maximum injectable volumes via tail vein are restricted by circulatory capacity. For mice, 5 mL/kg body weight is the standard single-dose limit for IV bolus administration. For continuous infusions, volume is governed by rate (2–4 mL/kg/hour) rather than a fixed volume ceiling. For rats, similar guidelines apply. Injection should be performed slowly to avoid cardiovascular stress — bolus doses are typically administered over 5–10 seconds; continuous infusions are administered at a weight-normalised rate (commonly 2–4 mL/kg/hour, per Turner et al. 2011, JAALAS) per institutional protocol. Hypertonic, high-pH, or highly viscous formulations cause greater vascular irritation and require particular care; where possible, formulate at physiological pH and osmolality.
Tail vein injection is used across a wide range of preclinical study types: pharmacokinetic and bioavailability studies requiring IV reference data, cancer research models using tail vein delivery of tumour cell suspensions, gene therapy studies using adeno-associated virus (AAV) or other viral vectors, and immunology experiments requiring IV delivery of cells or antibodies. The route provides the most rapid systemic exposure of any dosing route and is preferred when immediate onset of action or accurate IV pharmacokinetic parameters are required.
Key Points
- Lateral tail veins at 3 o'clock and 9 o'clock positions are the standard IV access sites in rodents
- Warm the tail by immersion in 38–40 °C water for 30–60 seconds to dilate veins before injection (do not exceed 40 °C)
- Use 27–30 gauge needles for mice, 25–27 gauge for rats; insert bevel-up at ~10–15°
- Subcutaneous bleb = missed vein; stop and reposition
- Volume guideline: up to 5 mL/kg IV bolus for mice and rats; continuous infusions at 2–4 mL/kg/hour (Turner et al. 2011, JAALAS)
Relevant Standards
- OECD Test Guidelines (specify IV dosing routes for relevant acute and repeated-dose studies)
- ARRIVE Guidelines (reporting standards for animal research — require documentation of dosing route, volume, and rate)
- Institutional animal ethics committee (AEC in Australia; IACUC in North America) protocols govern approved volumes and technique
Related Terms
Related Articles
Frequently Asked Questions
How do I know if my tail vein injection was successful?
A successful injection feels smooth with no resistance, and you will not see a subcutaneous bleb (raised swelling) at the injection site. In pale-tailed animals, you may see the vein lumen blanch (clear) as the injectate displaces blood within the vessel. If you feel resistance or see a bleb forming, stop immediately — the needle tip is outside the vein. Withdraw, apply gentle pressure for a moment, then attempt injection at a more proximal (closer to the body) site.
What is the best way to warm the tail for tail vein injection in mice?
Warm water immersion (38–40 °C for 30–60 seconds) is the most controlled and reproducible method. Heat lamps and warm pads are also used but require care to avoid overheating. The goal is vasodilation so the lateral veins are visible and palpable. Do not use water hotter than 40 °C — temperatures above this risk thermal injury and animal distress, and are inconsistent with current NC3Rs welfare guidance.
What needle gauge should I use for tail vein injection in mice?
27- to 30-gauge needles are standard for tail vein injection in mice. A 27-gauge needle is a good starting point for most applications; finer gauges (29–30) are used for viscous formulations where a smaller needle reduces pain and tissue damage despite the higher injection force required. For rats, use 25–27 gauge.
What is the maximum volume for tail vein injection in mice?
A guideline of 5 mL/kg body weight is the standard limit for IV bolus administration, meaning a 25 g mouse can receive up to approximately 125 µL. For continuous infusions, volume is governed by rate rather than a fixed ceiling — Turner et al. 2011 (JAALAS) recommends 2–4 mL/kg/hour. Exceeding recommended rates and volumes risks cardiovascular overload and dilution of blood electrolytes. Always confirm approved volumes and rates with your institutional animal ethics committee.